Literature DB >> 25813079

NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.

Fabio Forghieri1, Ambra Paolini1, Monica Morselli1, Sara Bigliardi1, Goretta Bonacorsi1, Giovanna Leonardi1, Valeria Coluccio1, Monica Maccaferri1, Valeria Fantuzzi1, Laura Faglioni1, Elisabetta Colaci1, Francesco Soci1, Vincenzo Nasillo1, Andrea Messerotti1, Laura Arletti1, Valeria Pioli1, Patrizia Zucchini1, Chiara Quadrelli1, Giorgia Corradini1, Francesca Giacobbi1, Daniela Vallerini1, Giovanni Riva1, Patrizia Barozzi1, Ivana Lagreca1, Roberto Marasca1, Franco Narni1, Cristina Mecucci2, Emanuela Ottaviani3, Giovanni Martinelli3, Brunangelo Falini2, Mario Luppi1, Leonardo Potenza1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25813079     DOI： 10.3109/10428194.2015.1026900

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  9 in total

1.  Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms.

Authors:  Sanjay S Patel; Caleb Ho; Ryan N Ptashkin; Sam Sadigh; Adam Bagg; Julia T Geyer; Mina L Xu; Thomas Prebet; Emily F Mason; Adam C Seegmiller; Elizabeth A Morgan; David P Steensma; Eric S Winer; Waihay J Wong; Robert P Hasserjian; Olga K Weinberg
Journal:  Blood Adv       Date:  2019-05-14

2.  NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy.

Authors:  Guillermo Montalban-Bravo; Rashmi Kanagal-Shamanna; Koji Sasaki; Keyur Patel; Irene Ganan-Gomez; Elias Jabbour; Tapan Kadia; Farhad Ravandi; Courtney DiNardo; Gautham Borthakur; Koichi Takahashi; Marina Konopleva; Rami S Komrokji; Amy DeZern; Teodora Kuzmanovic; Jaroslaw Maciejewski; Sherry Pierce; Simona Colla; Mikkael A Sekeres; Hagop Kantarjian; Carlos Bueso-Ramos; Guillermo Garcia-Manero
Journal:  Blood Adv       Date:  2019-03-26

Review 3.  Evidence-Based Minireview: Molecular precision and clinical uncertainty: should molecular profiling be routinely used to guide risk stratification in MDS?

Authors:  Daniel R Richardson; Amy E DeZern
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 4.  Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria.

Authors:  Maria Sanz-De Pedro; Wei Wang; Rashmi Kanagal-Shamanna; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

Review 5.  Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies.

Authors:  Vincenzo Nasillo; Giovanni Riva; Ambra Paolini; Fabio Forghieri; Luca Roncati; Beatrice Lusenti; Monica Maccaferri; Andrea Messerotti; Valeria Pioli; Andrea Gilioli; Francesca Bettelli; Davide Giusti; Patrizia Barozzi; Ivana Lagreca; Rossana Maffei; Roberto Marasca; Leonardo Potenza; Patrizia Comoli; Rossella Manfredini; Antonino Maiorana; Enrico Tagliafico; Mario Luppi; Tommaso Trenti
Journal:  Int J Mol Sci       Date:  2021-02-14       Impact factor: 5.923

Review 6.  Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.

Authors:  Fabio Forghieri; Patrizia Comoli; Roberto Marasca; Leonardo Potenza; Mario Luppi
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

Review 7.  NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?

Authors:  Fabio Forghieri; Vincenzo Nasillo; Ambra Paolini; Francesca Bettelli; Valeria Pioli; Davide Giusti; Andrea Gilioli; Corrado Colasante; Gloria Acquaviva; Giovanni Riva; Patrizia Barozzi; Rossana Maffei; Leonardo Potenza; Roberto Marasca; Claudio Fozza; Enrico Tagliafico; Tommaso Trenti; Patrizia Comoli; Giuseppe Longo; Mario Luppi
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

8.  Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes.

Authors:  Nehakumari Maurya; Purvi Mohanty; Somprakash Dhangar; Purvi Panchal; Farah Jijina; S Leo Prince Mathan; Chandrakala Shanmukhaiah; Manisha Madkaikar; Babu Rao Vundinti
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

Review 9.  The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms.

Authors:  Katalin Kelemen
Journal:  Life (Basel)       Date:  2022-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.